ABVC BioPharma, Inc. (ECOC) Operating income 2017–2025
ABVC BioPharma, Inc. (ECOC) annual operating income history from SEC filings — each fiscal year as reported.
-$7.2MFY2025 · since FY2017: -$4.1M → -$7.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.2M | -52.0% |
| FY2024 | -$4.7M | +30.5% |
| FY2023 | -$6.8M | +55.2% |
| FY2022 | -$15.1M | -29.1% |
| FY2021 | -$11.7M | -37.6% |
| FY2020 | -$8.5M | -145.9% |
| FY2019 | -$3.5M | -24.2% |
| FY2018 | -$2.8M | +32.7% |
| FY2017 | -$4.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ECOC financial trends
ECOC RevenueECOC Net incomeECOC Net marginECOC Gross profitECOC Gross marginECOC Operating marginECOC Operating cash flowECOC Free cash flowECOC Capital expendituresECOC Return on equityECOC Stock buybacksECOC Dividends paidECOC Total assetsECOC Total liabilitiesECOC Shareholders’ equityECOC overview →